Results of a study by Greek researchers suggest that percutaneous disc decompression, a newly developed outpatient procedure for herniated vertebral discs, has better long-term effects than conservative therapy.
Results of a study by Greek researchers suggest that percutaneous disc decompression, a newly developed outpatient procedure for herniated vertebral discs, has better long-term effects than conservative therapy. They released findings at the 2009 RSNA meeting.
Percutaneous disc decompression involves inserting a needle into a herniated disc and removing tissue under an imaging guidance system. The procedure, which is done under local anesthetic, is minimally invasive and takes 15 to 60 minutes, depending on the number of discs being treated.
“This is for patients who do not have a motor deficit. They can walk normally, but they're in pain,” said Dr. Alexis Kelekis, an assistant professor of interventional radiology at the University of Athens.
The study consisted of two groups with 31 patients each, all of whom had a history of unsuccessful medical treatment for back or leg pain. One group was randomly assigned to undergo the interventional treatment, which Kelekis described as slightly painful. The other group underwent rigorous conservative therapy, which included physiotherapy and anti-inflammatory drugs. There were no previous differences between the two groups.
Patients who were chosen to participate had clinical symptoms that were concordant with their herniated discs. Patients in both groups reported positive results after three months. Those who underwent the percutaneous disc treatment continued to report decreased pain at 12- and 24-month follow-up. Those under rigorous conservative therapy, however, reported increased pain and decreased mobility after 12 months. Their negative symptoms increased through the 24-month period.
“The effect of the drugs lasts for a while, but slowly the pain comes back. You have to retake the drugs and restart the cycle,” Kelekis said.
According to Kelekis, patients who underwent the percutaneous disc treatment had a slower curve in the beginning, but its effect was sustained over the 24-month follow-up period. While some patients had immediate positive results, the complete effect took approximately three to six months.
“In a way we're imitating what nature will do in the following years by mechanically degenerating those discs,” Kelekis said.
Kelekis stressed the importance of talking to the patient about both the procedure itself and other relevant clinical information.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.